Image

A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions

Study compares biodegradable matrix vs. cadaver skin for skin reconstruction.

Recruiting
18 years and older
All
Phase 4

Study Overview: This study will compare two treatments for wounds from a condition called Hidradenitis Suppurativa (HS). HS is a skin disease that causes lumps under the skin. The study will have 10 patients, with 5 using a special biodegradable matrix (BTM) and 5 using cadaver skin, which is skin from a deceased person.

Treatment Details: After cleaning the wound, doctors will put either BTM or cadaver skin on it. They will cover it with special dressings to protect it. Visits to the clinic will happen regularly, like once a week, to check how well the wound is healing. The study lasts for up to 12 months, with long-term follow-ups.

Key Points to Consider:

  • Length of Study: The study has regular follow-ups and lasts up to 12 months.
  • Visits Required: Weekly clinic visits and long-term assessments at 3, 6, and 12 months are needed.
  • Eligibility: Must be 18 or older, with severe HS needing surgery, and cannot have certain health risks.

Eligibility: Participants must be 18 or older, diagnosed with severe HS, and willing to follow study procedures. Certain health conditions can exclude participation.

Study details
    Hidradenitis Suppurativa

NCT05477225

Joseph M. Still Research Foundation, Inc.

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.